Delivery Order SPE2DB25D3201-SPE2DB25FNSME
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,047.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of June 9, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $2,659.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with an ultimate completion date of April 16, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
This federal contract award, valued at $2,071.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of May 21, 2025 and is a Firm Fixed Price arrangement. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $39,205.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of March 4, 2025. The contract is a Delivery Order under a Firm Fixed Price type, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,187.46, is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of September 25, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $6,221.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is part of Amerisourcebergen's larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,753.98 firm fixed price delivery order is for WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on May 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $41,692.55 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to deliver a wide range of medical commodities and pharmaceuticals in support of military treatment programs and facilities worldwide....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,095.00 firm fixed-price delivery order contract is for the provision of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of February 24, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $1,097.08 Firm Fixed Price contract is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a prescription medication. It is a Delivery Order contract with an ultimate completion date of April 16, 2024. The contract is not set-aside. Amerisourcebergen holds a larger...